Efficacy and Mechanism of Action of Sovleplenib for Aplastic Anemia

An immune-mediated aplastic anemia mouse model was established and treated with sovleplenib. Hematopoietic function was assessed via peripheral blood counts and bone marrow mononuclear cell counts.